DEL BELLO, Fabio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.203
EU - Europa 6.478
AS - Asia 4.842
SA - Sud America 664
AF - Africa 92
Continente sconosciuto - Info sul continente non disponibili 44
OC - Oceania 40
Totale 24.363
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.808
CN - Cina 2.099
RU - Federazione Russa 1.543
IT - Italia 1.378
SG - Singapore 1.339
DE - Germania 911
PL - Polonia 696
BR - Brasile 556
HK - Hong Kong 443
UA - Ucraina 361
GB - Regno Unito 329
CA - Canada 327
SE - Svezia 319
FI - Finlandia 272
VN - Vietnam 231
FR - Francia 207
TR - Turchia 165
KR - Corea 150
IE - Irlanda 109
IN - India 105
CZ - Repubblica Ceca 81
JP - Giappone 70
BE - Belgio 59
MX - Messico 54
NL - Olanda 48
AR - Argentina 43
PK - Pakistan 40
ZA - Sudafrica 39
ES - Italia 38
EU - Europa 38
AU - Australia 37
BD - Bangladesh 34
IQ - Iraq 27
IR - Iran 26
EG - Egitto 23
AT - Austria 21
EC - Ecuador 17
ID - Indonesia 16
LT - Lituania 14
UY - Uruguay 14
PT - Portogallo 13
HR - Croazia 12
PE - Perù 12
MY - Malesia 11
SA - Arabia Saudita 11
AE - Emirati Arabi Uniti 10
RO - Romania 10
BY - Bielorussia 9
HU - Ungheria 9
CO - Colombia 8
GR - Grecia 8
KE - Kenya 8
AZ - Azerbaigian 6
KG - Kirghizistan 6
PH - Filippine 6
UZ - Uzbekistan 6
VE - Venezuela 6
A2 - ???statistics.table.value.countryCode.A2??? 5
CH - Svizzera 5
DK - Danimarca 5
IL - Israele 5
LV - Lettonia 5
RS - Serbia 5
TW - Taiwan 5
CL - Cile 4
NP - Nepal 4
AL - Albania 3
DZ - Algeria 3
GE - Georgia 3
JM - Giamaica 3
JO - Giordania 3
KH - Cambogia 3
LK - Sri Lanka 3
MA - Marocco 3
PS - Palestinian Territory 3
QA - Qatar 3
SN - Senegal 3
TH - Thailandia 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
BG - Bulgaria 2
BO - Bolivia 2
GH - Ghana 2
IS - Islanda 2
NG - Nigeria 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
PY - Paraguay 2
BS - Bahamas 1
BW - Botswana 1
BZ - Belize 1
CR - Costa Rica 1
CY - Cipro 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
Totale 24.353
Salva come PNG Salva come JPEG
Città #
Dallas 1.307
Ashburn 927
Fairfield 925
Jacksonville 864
Woodbridge 819
Chandler 602
Singapore 596
Warsaw 566
Houston 521
Ann Arbor 517
Wilmington 458
Hong Kong 427
Boardman 425
Seattle 370
Beijing 357
Camerino 351
Cambridge 293
Nanjing 275
Toronto 229
Los Angeles 209
Dearborn 203
New York 202
Seoul 144
San Mateo 140
Tongling 140
Lawrence 130
Princeton 129
Helsinki 127
The Dalles 126
Istanbul 122
Kraków 113
Munich 111
Dublin 110
Columbus 107
Nanchang 103
Ogden 96
Düsseldorf 93
Moscow 93
London 88
Buffalo 86
Milan 82
Shanghai 74
Ho Chi Minh City 73
Shenyang 67
Guangzhou 62
São Paulo 58
Jiaxing 57
Kunming 57
Brno 56
Tokyo 55
Chicago 52
Brussels 51
Hanoi 50
Lachine 50
Jinan 48
Tianjin 48
Santa Clara 47
Turku 47
San Diego 45
Changsha 39
Hebei 39
Bremen 38
Centro 36
Rome 36
Philadelphia 34
Frankfurt am Main 32
Phoenix 32
Zhengzhou 31
Denver 30
Brooklyn 29
Dong Ket 29
Redondo Beach 29
Stockholm 29
Redwood City 27
Chennai 26
Hangzhou 26
Montreal 26
Poplar 26
Wuhan 26
Venezia 25
Johannesburg 24
Mexico City 24
Ningbo 24
Nuremberg 23
Hefei 22
Orem 22
Leawood 21
Manchester 21
Perugia 21
Atlanta 20
Council Bluffs 20
Falls Church 19
Monmouth Junction 19
Boston 18
Olomouc 18
Taizhou 18
Orange 17
Pesaro 17
Washington 17
Ankara 16
Totale 15.626
Salva come PNG Salva come JPEG
Nome #
1,4-Dioxane, a Suitable Scaffold for the Development of Novel M3 Muscarinic Receptor Antagonists 591
1,4-DIOXANE NUCLEUS AS A SUITABLE SCAFFOLD FOR NOVEL D2-LIKE RECEPTOR LIGANDS 585
1,4-Dioxane nucleus as a suitable scaffold in the building of ligands interacting with NMDA and σ1 receptors 528
1,4-Dioxane ring as a promising template of novel 5-HT1A full agonists 520
1,3-Dioxane as a scaffold for potent and selective 5-HT1AR agonist with in-vivo anxiolytic, anti-depressant and anti-nociceptive activity 493
An Efficient Lewis Acid Catalyzed Povarov Reaction for the One-Pot Stereocontrolled Synthesis of Polyfunctionalized Tetrahydroquinolines 325
1,4-Dioxane Nucleus as a Suitable Scaffold for the Characterization of Different Receptor Systems 321
The Versatile 2-Substituted Imidazoline Nucleus as a Structural Motif of Ligands Directed to the Serotonin 5-HT1A Receptor 312
1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1) as a Model for the Rational Design of a Novel Class of Brain Penetrant Ligands with High Affinity and Selectivity for Dopamine D4 Receptor 307
Antagonism/Agonism modulation to build novel antihypertensives selectively triggering i1-imidazoline receptor activation 306
Novel Potent N-Methyl-d-aspartate (NMDA) Receptor Antagonists or σ1 Receptor Ligands Based on Properly Substituted 1,4-Dioxane Ring 286
Exploring the Role of N6‐Substituents in Potent Dual Acting 5'‐C‐Ethyltetrazolyladenosine Derivatives: Synthesis, Binding, Functional Assays, and Antinociceptive Effects in Mice 286
TP53 mutant MDM2-amplified cell lines selected for resistance to MDM2-p53 binding antagonists retain sensitivity to ionizing radiation 285
Novel triazolium based 11th group NHCs: synthesis, characterization and cellular response mechanisms 283
A Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline Nucleus 277
Ethylenedioxy homologs of N-methyl-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) and its corresponding cathinone analog methylenedioxymethcathinone: Interactions with transporters for serotonin, dopamine, and norepinephrine 269
Combined Interactions with I1-, I2-Imidazoline Binding Sites and α2-Adrenoceptors To Manage Opioid Addiction 264
33rd camerino-Cyprus Symposium - Receptor Chemistry: Reality and Vision 245
31st Camerino-Cyprus-Noordwijkerhout Symposium - Receptor Chemistry Skyline 243
Novel antitumor copper(ii) complexes designed to act through synergistic mechanisms of action, due to the presence of an NMDA receptor ligand and copper in the same chemical entity 242
Investigation of allyphenyline efficacy in the treatment of alcohol withdrawal symptoms 235
Investigation of the Role of Chirality in the Interaction with σ Receptors and Effect on Binge Eating Episode of a Potent σ1 Antagonist Analogue of Spipethiane 235
Favourable involvement of α2A-adrenoreceptor antagonism in the I₂-imidazoline binding sites-mediated morphine analgesia enhancement. 231
Receptor Ligands as Helping Hands to L-DOPA in the Treatment of Parkinson's Disease 226
Biological profile and bioavailability of imidazoline compounds on morphine tolerance modulation 221
The replacement of the 2-methoxy substituent of N-((6,6-diphenyl-1,4-dioxan-2-yl)methyl)-2-(2-methoxyphenoxy)ethan-1-amine improves the selectivity for 5-HT1A receptor over α1-adrenoceptor and D2-like receptor subtypes 221
Multitarget 1,4-Dioxane Compounds Combining Favorable D2-like and 5-HT1A Receptor Interactions with Potential for the Treatment of Parkinson's Disease or Schizophrenia 221
Structure-Based Design, Synthesis and in vivo Antinociceptive Effects of Selective A1 Adenosine Receptor Agonists 218
Mode of interaction of 1,4-dioxane agonists at the M2 and M3 muscarinic receptor orthosteric sites 212
Identification of 2-aminopyrimidine derivatives as inhibitors of the canonical Wnt signaling pathway 211
Rapid novel divergent synthesis and muscarinic agonist profile of all four optical isomers of N,N,N-trimethyl(6-methyl-1,4-dioxan-2-yl)methanaminium iodide. 197
From the covalent linkage of drugs to novel inhibitors of ribonucleotide reductase: synthesis and biological evaluation of valproic esters of 3'-C-methyladenosine 196
Novel 1,4-dioxane derivatives as NMDA receptor channel blockers 196
Role of the NMDA Receptor in the Antitumor Activity of Chiral 1,4-Dioxane Ligands in MCF-7 and SKBR3 Breast Cancer Cells 195
33rd Camerino-Cyprus Symposium - Receptor Chemistry: Reality and Vision 194
Novel Highly Potent and Selective σ1 Receptor Antagonists Related to Spipethiane 191
Design, Synthesis and Biological Evaluation of Novel Chemical Entities as Potential Anticancer Drugs and for the Control of the Metastatic Process 188
Chemical manipulations on the 1,4-dioxane ring of 5-HT1A receptor agonists lead to antagonists endowed with antitumor activity in prostate cancer cells 188
31st Camerino-Cyprus-Noordwijkerhout Symposium - Receptor Chemistry Skyline 187
Roles of Wnt/β-catenin signalling pathway in the bony repair of injured growth plate cartilage in young rats 185
77-LH-28-1 as a model for the rational design of selective dopamine D4 receptor ligands 185
Structure−Activity Relationships in 1,4-Benzodioxan-Related Compounds. 11.1 Reversed Enantioselectivity of 1,4-Dioxane Derivatives in α1‑Adrenergic and 5‑HT1A Receptor Binding Sites Recognition 184
Low doses of allyphenyline and cyclomethyline, effective against morphine dependence, elicit an antidepressant-like effect 184
Synthesis and cytotoxic activity evaluation of new Cu(I) complexes of bis(pyrazol-1-yl) acetate ligands functionalized with an NMDA receptor antagonist 182
28th Camerino-Cyprus-Noordwijkerhout Symposium - Trekking through Receptor Chemistry 180
Synthesis of Triazole-Linked Analogues of c‐di-GMP and Their Interactions with Diguanylate Cyclase 179
Potent muscarinic antagonists bearing 1,4-dioxane scaffold 178
Complessi di rame(I) con leganti tris(azolil)borati e fosfine monodentate: sintesi e studi biologici 178
Properly substituted 1,4-dioxane nucleus favours the selective M3 muscarinic receptor activation 177
Effects of imidazoline I2 receptor ligands on acute nociception in rats 177
Synthesis and Biological Evaluation of a Novel Series of Heterobivalent Muscarinic Ligands Based on Xanomeline and 1‑[3- (4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77- LH-28-1) 174
Might Adrenergic alpha2C-agonists/alpha2A-antagonists become novel therapeutic tools for pain treatment with morphine? 174
Solution-phase synthesis of ICG-001, a beta-turn peptidomimetic molecule inhibitor of beta-catenin-Tcf-mediated transcription 172
Exploring multitarget interactions to reduce opiate withdrawal syndrome and psychiatric comorbidity 172
BIOLOGICAL PROFILE AND BIOAVAILABILITY OF IMIDAZOLINE COMPOUNDS AFFECT THEIR MODULATORY ACTIVITY ON MORPHINE TOLERANCE 171
Rational design and biological evaluation of novel conjugated heteroscorpionate ligands and related Copper(I/II) complexes 171
Front Cover, European Journal of Medicinal, Issue 146, 25 February 2018. 171
4WD to Travel Inside the 5-HT1A Receptor World 171
Allyphenyline analogues potentially useful in the management of chronic pain and opioid addiction. 169
Adenosine receptors as promising targets for the management of ocular diseases 169
Novel Potent 5-HT1a Agonists Selective over alpha1-Adrenoceptor Subtypes 168
Dioxane and Oxathiane Nuclei: Suitable Substructures for Muscarinic Agonists 166
Structurally diverse MDM2–p53 antagonists act as modulators of MDR-1 function in neuroblastoma 165
New insights in Au-NHCs complexes as anticancer agents 163
Dual Alpha2C/5HT1A Receptor Agonist Allyphenyline Induces Gastroprotection and Inhibits Fundic and Colonic Contractility 163
Fruitful Adrenergic alpha(2C)-Agonism/alpha(2A)-Antagonism Combination to Prevent and Contrast Morphine Tolerance and Dependence 162
Novel highly potent and selective sigma1 receptor antagonists effectively block the binge eating episode in female rats 159
DOPAMINE D2, D3, AND D4 RECEPTOR AFFINITIES OF 77-LH-28-1 AND ITS ANALOGUES 158
Novel muscarinic acetylcholine receptor hybrid ligands embedding quinuclidine and 1,4-dioxane fragments 158
The 2-substituted imidazoline ring linked to an aromatic moiety by a biatomic bridge: a bioversatile scaffold 158
Activation of primary amines by copper(I)-based Lewis acid promoters in the solventless synthesis of secondary propargylamines 158
Enantioselective interactions to improve adrenergic α2C-agonism/α2A-antagonism 156
TESTING D2-LIKE RECEPTOR AFFINITY AND SELECTIVITY WITH NOVEL IMIDAZOLINE DERIVATIVES 156
NOVEL BIVALENT LIGANDS OF XANOMELINE AND 77-LH-28-1 AS POTENTIAL M1 MUSCARINIC AGONISTS 156
Might adrenergic α2C-agonist/α2A-antagonist become a novel therapeutic multitarget tool for morphine chronic treatment of pain? 153
Biguanide derivatives as surfactants and antimicrobial agents for pharmaceutical applications 153
From benzodioxane to 1,4-dioxane scaffold in the design of 5-HT1A serotoninergic full agonists from α1-adrenergic antagonists 150
Structure-activity relationships in 1,4-benzodioxan-related compounds. 9.From 1,4-benzodioxan to 1,4-dioxane ring as a promising template of novel alpha(1D)-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents. 144
Trekking through receptor chemistry 141
Imidazoline nucleus as a biologically versatile scaffold 140
Effects of allyphenyline on chronic alcohol intoxication model 138
Efficient Lewis Acid Systems for the A3 Coupling reaction 138
MORPHINE TOLERANCE MODULATION INDUCED BY alpha2-ADRENERGIC OR/AND I2 IMIDAZOLINE BINDING SITES LIGANDS 137
NOVEL IMIDAZOLINE MOLECULES INSPIRED BY THE PHARMACOLOGICAL PROFILE OF AGMATINE AS POTENTIAL TOOLS IN MANAGING OPIOID ADDICTION 136
Hybrid molecules from xanomeline and 77-LH-28-1 as potential novel M1 muscarinic agonists 135
null 132
Assessing the role of ghrelin and the enzyme ghrelin O-acyltransferase (GOAT) system in food reward, food motivation, and binge eating behavior 132
Advances in the Development of Nonpeptide Small Molecules Targeting Ghrelin Receptor 132
Design, synthesis, reactivity, biological and catalytic applications of functionalized bis(pyrazolyl)acetate copper complexes 129
null 129
Design and synthesis of novel imidazoline derivatives potentially targeting dopamine receptors 128
Advances in drug design and therapeutic potential of selective or multitarget 5‐HT1A receptor ligands 127
Molecular determinants in the binding of novel 1,4-benzodioxan-related α1D-adrenergic receptor antagonists: a computational study 127
Aminopyrimidines as inhibitors of the Wnt signalling pathway 125
Copresence of 1,4-dioxane and quinuclidine nuclei in the design of novel muscarinic antagonists 121
Structure-activity relationships in 1,4-benzodioxan-related compounds. 9. From 1,4-benzodioxane to 1,4-dioxane ring as a promising template of novel alpha1D-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents. 121
Structure-activity relationships in 1,4-benzodioxan-related compounds. 10. Novel alpha1-adrenoreceptor antagonists related to openphendioxan: synthesis, biological evaluation, and alpha1d computational study 120
Enantiomers of 6,6-diphenyl-1,4-dioxane derivatives to highlight stereochemical requirements for selective alpha1D-AR and 5- HT1A receptor recognition 119
Might the observed alpha2A-adrenoreceptor agonism or antagonism of allyphenyline analogues be ascribed to different molecular conformations? 117
Chemistry and antitumor investigations of new Cu(I) complexes of bis(pyrazol-1-yl)acetate ligands functionalized with an NMDA receptor antagonist 117
Totale 20.321
Salva come PNG Salva come JPEG
Categoria #
all - tutte 100.938
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.938
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.662 0 0 0 0 0 171 345 112 213 158 430 233
2021/20221.428 122 359 38 58 93 63 46 111 122 165 85 166
2022/20231.867 232 71 89 237 186 214 20 118 360 106 152 82
2023/20241.608 195 94 131 52 68 175 76 57 159 62 43 496
2024/20255.150 241 112 427 246 194 266 606 1.176 437 325 335 785
2025/20265.119 492 575 1.603 1.191 806 452 0 0 0 0 0 0
Totale 24.864